Ignite Creation Date:
2024-05-06 @ 2:21 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02023905
Status:
TERMINATED
Last Update Posted:
2022-12-29
First Post:
2013-12-24
Brief Title:
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
Novartis-CRAD001CUS225T
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of California San Francisco
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis | INDUSTRY |